BAJAJ BROKING

Notification close image
No new Notification messages
card image
Accretion Pharmaceuticals IPO is Open!
Apply for the Accretion Pharmaceuticals IPO through UPI in just minutes.
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

How to Apply for Accretion Pharmaceuticals IPO?

To apply for the Accretion Pharmaceuticals IPO, investors can log in to their trading accounts via their respective brokers and navigate to the IPO section. From there, they must select "Accretion Pharmaceuticals IPO," enter the number of lots (minimum 1200 shares), choose the bid price within the ₹96–₹101 range, and submit their UPI ID for payment. Ensure the UPI mandate is approved by 5 PM on May 16, 2025. To check the allotment status, applicants can visit the registrar’s website—Kfin Technologies Limited—after the tentative allotment date of May 19, 2025, and enter their application details such as PAN, DP ID, or application number to view the status.

For complete details on this public offering, visit the Accretion Pharmaceuticals IPO page on Bajaj Broking’s website.

Accretion Pharmaceuticals IPO Application Process

The Accretion Pharmaceuticals IPO application process can be completed online through your trading platform. Below is a step-by-step guide to applying for the IPO:

Step 1: Login to Your Trading Platform

Access your trading account using Bajaj Broking’s app or website.

Step 2: Navigate to the IPO Section

Go to the IPO section to view active IPO listings.

Step 3: Select the Open IPO and Click Apply

Locate Accretion Pharmaceuticals IPO in the list of available IPOs and click the ‘Apply’ button.

Step 4: Enter the Quantity of Shares You Wish to Apply For

Specify the number of shares (minimum lot size: 1200 shares) within the price band of ₹96 to ₹101 per share.

Step 5: Provide Your UPI ID

Enter your UPI ID for payment authorization and ensure sufficient funds in your bank account.

Step 6: Confirm the Application

Review your application details and confirm the UPI mandate before 5 PM on the last application day.

Step 7: Complete the Process and Wait for Allotment

Submit the application and monitor the allotment status to check if shares have been allocated to you.

How to Check Accretion Pharmaceuticals IPO Allotment Status?

Once the allotment for Accretion Pharmaceuticals IPO is finalized, investors can check their status online using the following steps:

Step 1: Visit the Official Website of the IPO's Registrar

Access the registrar’s portal for allotment status updates.

Step 2: Navigate to the IPO Allotment Status Page

Locate the specific section for IPO allotment on the website.

Step 3: Enter Your PAN Number, Demat ID, or Application Number

Provide the necessary details to retrieve your application status.

Step 4: Click on 'Submit' or 'Check Status'

Verify the allotment details displayed on the screen.

Step 5: Alternative Check on Stock Exchange Websites

Visit SME or NSE websites and follow the IPO allotment instructions.

Step 6: Check via Bajaj Broking Website

Log in to Bajaj Broking, access the IPO section, and view your allotment updates in the IPO Allotment Status.

About Accretion Pharmaceuticals IPO: Overview and Key Facts

Accretion Pharmaceuticals Limited, established in 2012, is a pharmaceutical company based in Sanand, Ahmedabad, Gujarat. The company specializes in the manufacturing and marketing of a diverse range of healthcare products, including tablets, capsules, oral liquids, oral powders (such as sachets and dry syrups), and external preparations like ointments, creams, gels, lotions, medicated shampoos, mouthwash, and dusting powders. In addition to direct sales, Accretion Pharmaceuticals offers contract and loan license manufacturing services to various third-party marketers, operating primarily on a principal-to-principal basis. The company's manufacturing facility is ISO 9001:2015, ISO 14001:2015, and ISO 22000:2018 certified, reflecting its adherence to quality, safety, and environmental standards.

The Initial Public Offering (IPO) of Accretion Pharmaceuticals is scheduled to open for subscription from May 14 to May 16, 2025. The IPO comprises a fresh issue of 29,46,000 equity shares, aggregating up to ₹29.75 crore. The price band for the IPO is set between ₹96 to ₹101 per share, with a minimum lot size of 1,200 shares. The shares are proposed to be listed on the NSE SME platform. The lead manager for the issue is Jawa Capital Services Private Limited, and the registrar is KFin Technologies Limited. The market maker for the IPO is Gretex Share Broking Private Limited.

The proceeds from the IPO are intended to be utilized for capital expenditure towards the purchase of new equipment and machinery, upgradation of the existing manufacturing facility, repayment or prepayment of certain borrowings, funding working capital requirements, and general corporate purposes. This strategic move aims to enhance the company's operational capabilities and support its growth initiatives. Investors interested in applying for the IPO can do so through their trading accounts by navigating to the IPO section, selecting "Accretion Pharmaceuticals IPO," entering the required details, and completing the application process using UPI or ASBA payment methods.

To check your application status, visit the Accretion Pharmaceuticals IPO Allotment Status page on Bajaj Broking’s website.

Share this article: 

Frequently Asked Questions

No result found

search icon

Read More Blogs

Disclaimer :

The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes.

The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.

Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

[ Read More ]

For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

10 lakh+ Users

icon-with-text

4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300+ Cr MTF Book

icon-with-text
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|